Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3731271
Max Phase: Preclinical
Molecular Formula: C16H10O5
Molecular Weight: 282.25
Molecule Type: Small molecule
Associated Items:
ID: ALA3731271
Max Phase: Preclinical
Molecular Formula: C16H10O5
Molecular Weight: 282.25
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)/C=C/c1c2ccc(=O)cc-2oc2cc(O)ccc12
Standard InChI: InChI=1S/C16H10O5/c17-9-1-3-12-11(5-6-16(19)20)13-4-2-10(18)8-15(13)21-14(12)7-9/h1-8,17H,(H,19,20)/b6-5+
Standard InChI Key: GKEOQSRVZYLDTJ-AATRIKPKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 282.25 | Molecular Weight (Monoisotopic): 282.0528 | AlogP: 2.70 | #Rotatable Bonds: 2 |
Polar Surface Area: 87.74 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.73 | CX Basic pKa: 2.86 | CX LogP: 1.43 | CX LogD: -2.47 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.56 | Np Likeness Score: 0.89 |
1. (2010) Compositions and methods for inhibiting g protein signaling, |
Source(1):